Aligos Therapeutics Inc.
ALGS | NASDAQ
$5.87
+$0.38 (+6.92%)
Sep 22, 2026, 11:44 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -3.80 | -1.90 | -4.72 | -10.59 | -92.16 | -217.37 |
PEG Ratio | 0.04 | 0 | -0.08 | 0.35 | -73.27 | -6.47 |
PS Ratio | 42.14 | 63.27 | 26.59 | 73.13 | 2.71K | n/a |
PB Ratio | 1.72 | -8.61 | 4.48 | 9.79 | 64.02 | 107.37 |
P/FCF Ratio | -1.11 | -3.09 | -5.23 | -12.66 | -101.47 | -309.53 |
P/OCF Ratio | -1.12 | -3.09 | -5.23 | -12.81 | -102.26 | -318.13 |
OCF/S Ratio | -3.77K | -2.05K | -508.71 | -570.86 | -2.65K | n/a |
Debt / Equity Ratio | 0.10 | -0.29 | 0.12 | 0.12 | 0.08 | 0.06 |
Quick Ratio | 3.90 | 2.86 | 5.90 | 4.03 | 5.25 | 8.26 |
Current Ratio | 3.90 | 2.86 | 5.90 | 4.03 | 5.25 | 8.26 |
Asset Turnover | 0.02 | 0.06 | 0.10 | 0.09 | 0.02 | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | -9.28 |
Return on Equity | -45.18% | 452.87% | -95.22% | -92.44% | -69.47% | -49.33% |
Return on Assets | -27.33% | -187.19% | -57.86% | -65.47% | -54.52% | -40.91% |
Return on Invested Capital | -123.88% | -172.06% | -67.34% | -83.61% | -64.38% | -41.19% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 57.46% | 100% | 100% | 100% | 100% | n/a |
Net Profit Margin | -1.11K% | -3.33K% | -564.61% | -690.63% | -2.94K% | n/a |
Pretax Profit Margin | -1.09K% | -3.32K% | -559.50% | -689.87% | -2.94K% | n/a |
Operating Profit Margin | -4.02K% | -2.26K% | -567.50% | -701.66% | -2.94K% | n/a |
FCF Margin | -3.79K% | -2.05K% | -508.83% | -577.64% | -2.67K% | n/a |
EBITDA Margin | -1.05K% | -3.25K% | -539.73% | -663.44% | -2.85K% | n/a |
Add to Watchlist
Select watchlists to add or remove ALGS